Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Pol S, Bourliere M, Lucier S, et al. Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. Hézode C, Dorival C, Larrey D, Bronowicki J-P, Ledinghen VDE, Zoulim F, et al. J Hepatol. 2017;66(1):39-47.

Publication Type:

Journal Article

Authors:

Stanislas Pol; Bourliere, Marc; Lucier, Sandy; et, al

Source:

J Hepatol, Volume 66, Issue 1, p.39-47 (2017)

Keywords:

Chronic hepatitis C, Cirrhosis, daclatasvir, Direct antiviral agents, genotype 1, Hepather cohort, Severe fibrosis, sofosbuvir, treatment

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/27622858

Export Citation:
RIS Format
Top